Shares of Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.10 and traded as high as $0.18. Enzon Pharmaceuticals shares last traded at $0.18, with a volume of 11,112 shares trading hands.
Enzon Pharmaceuticals Stock Performance
The business’s 50-day moving average is $0.12 and its 200 day moving average is $0.10.
About Enzon Pharmaceuticals
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
Read More
- Five stocks we like better than Enzon Pharmaceuticals
- Learn Technical Analysis Skills to Master the Stock Market
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- How to invest in blue chip stocks
- Progress Software Stock Back in the Green After Beating Forecasts
- Insider Trading – What You Need to Know
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
